Clinical trial

The Effect of Semaglutide on the Intestinal Flora in Obesity

NCT07323134

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Semaglutide Injection Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

The Effect of Semaglutide on the Intestinal Flora in Obesity

Design: OBSERVATIONAL · Status: NOT YET RECRUITING · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusNOT_YET_RECRUITING

Study typeOBSERVATIONAL

Start date2026-02-01

PhaseN/A

Conditions

Obesityverified · MONDO: obesity disorder

Interventions

Semaglutide InjectionDRUG

Sponsors & collaborators

Beijing Chao Yang Hospitallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07323134 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.